Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.
about
Should dual antiplatelet therapy be used in patients following coronary artery bypass surgery? A meta-analysis of randomized controlled trialsA systematic review of the quality of economic models comparing thrombosis inhibitors in patients with acute coronary syndrome undergoing percutaneous coronary intervention.The clinical efficacy and safety evaluation of ticagrelor for acute coronary syndrome in general ACS patients and diabetic patients: A systematic review and meta-analysis.Comparison of Clopidogrel With Prasugrel and Ticagrelor in Patients With Acute Coronary Syndrome: Clinical Outcomes From the National Cardiovascular Database ACTION RegistryTargeting platelet thrombin receptor signaling to prevent thrombosis."Real-World" Comparison of Prasugrel With Ticagrelor in Patients With Acute Coronary Syndrome Treated With Percutaneous Coronary Intervention in the United States.Clopidogrel, prasugrel or ticagrelor in patients with acute coronary syndromes undergoing percutaneous coronary intervention.Republished: Antiplatelet therapy for secondary prevention of coronary artery disease.One-year post-discharge resource utilization and treatment patterns of patients with acute coronary syndrome managed with percutaneous coronary intervention and treated with ticagrelor or prasugrel.One-Year Clinical Effectiveness Comparison of Prasugrel with Ticagrelor: Results from a Retrospective Observational Study using an Integrated Claims Database.Head to head comparison of Prasugrel versus Ticagrelor in patients with acute coronary syndrome: a systematic review and meta-analysis of randomized trials.Comparison of 4 different strategies of DAPT after PCI in ACS real world population from a Northern Italy registry.Comparative Effectiveness and Safety Analysis of Dual Antiplatelet Therapies Within an Integrated Delivery System.Post percutaneous coronary interventional adverse cardiovascular outcomes and bleeding events observed with prasugrel versus clopidogrel: direct comparison through a meta-analysis.
P2860
Q26782970-0D0BAFF4-5765-4ADB-8CAE-3528206E3551Q33413196-B036AD91-D27C-4D13-8326-99E61542B14CQ33699370-7F02E4F0-72A2-40E3-9151-952422B0ACF2Q33893906-27177A96-3375-440D-8347-4D82705D0C18Q37280316-5FF1E481-4A01-4B48-A370-FF307D5EFBBDQ37561275-35437EFD-86BE-4D03-9505-DE50AD3E9368Q40891280-5FC6FD7C-508D-47B5-AC93-092801983EEAQ40937889-7B89A6E0-5FF3-4413-BBD9-79998B414759Q45018958-3A60B29C-A010-45B7-9130-46D7E67914F0Q46130127-0E7DF438-2C4C-41A3-B920-CF0A986E5C72Q47109165-104442B2-7340-4B35-8504-BAA34FBB563DQ48636205-E9E77A2F-1210-4099-8931-BC4E787E85D4Q51037939-C5295F1D-8E96-4736-A46D-584B980F6A1FQ55004314-CC090643-12D4-4049-B319-11B7BEC5EEDD
P2860
Comparing newer oral anti-platelets prasugrel and ticagrelor in reduction of ischemic events-evidence from a network meta-analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Comparing newer oral anti-plat ...... from a network meta-analysis.
@en
type
label
Comparing newer oral anti-plat ...... from a network meta-analysis.
@en
prefLabel
Comparing newer oral anti-plat ...... from a network meta-analysis.
@en
P2093
P2860
P31
P1476
Comparing newer oral anti-plat ...... e from a network meta-analysis
@en
P2093
Abhimanyu Ghose
Abhishek Sharma
Robert Frankel
Saurav Chatterjee
P2860
P2888
P304
P356
10.1007/S11239-012-0838-Z
P577
2013-10-01T00:00:00Z